comparemela.com

Latest Breaking News On - Antisense oligonucleotide - Page 9 : comparemela.com

Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks

Delhi HC issues notice to Centre on plea of 11-year-old child suffering from rare disease

India News | Delhi HC Issues Notice to Centre on Plea of 11-year-old Child Suffering from Rare Disease

Get latest articles and stories on India at LatestLY. Justice Prathiba M Singh on Friday issued notice to the Ministry of Health and Family Welfare on the plea and listed the matter on April 13 for further hearing. India News | Delhi HC Issues Notice to Centre on Plea of 11-year-old Child Suffering from Rare Disease.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.